The lymphotoxin b receptor (LTbR), and its ligand, LTa1b2, have been proposed to play a key role in the development and organization of lymphoid tissues. The LTbR is expressed on a variety of human primary and transformed cells, but strikingly absent on T or B lymphocytes and primary monocytes or peripheral dendritic cells, although LTbR is detected on some myeloid leukemic lines. In the developing thymus LTbR is prominent along the trabeculae and into the medulla upto corticomedullary junction. In the spleen, LTbR is prominently expressed by cells in the red pulp and along the borders of red and white pulp which colocalizes with reticular stromal cells. The LTbR is expressed on a human follicular dendritic cell line, FDC-1, and signals expression of CD54 when ligated with the LTa1b2 complex. These results support the concept that directional interactions between LTa1b2 bearing lymphocytes and LTbR bearing stromal cells are involved in the organization of lymphoid tissue.
Introduction
The lymphotoxin b receptor (LTbR) is a member of the TNF receptor family that has been proposed to play a role in the development and organization of lymphoid tissues (Beutler and vanHuffel, 1994; Ware et al, 1995) . Unlike the other TNF receptors (TNFR), LTbR does not bind soluble ligand, but rather, a membrane form of lymphotoxin (LT) (Crowe et al, 1994) comprised of one LTa and two LTb molecules (LTa1b2) Browning et al, 1993; . The LTb subunit is a 33 kDa type II transmembrane protein that serves as an anchor for LTa, which lacks a transmembrane domain Browning et al, 1991; Ware et al, 1992) . No secreted form of LTa1b2 has been identified, implying that signaling through the LTbR/LTa1b2 interaction requires cell to cell contact . LTa is also secreted as a homotrimer which binds either the 55 ± 60 kDa TNFR (TNFR60, CD 120a) or the 75 ± 80 kDa TNFR (TNFR80, CD120b) (Beutler and vanHuffel, 1994; Ware et al, 1995; Vilcek and Lee, 1991) . In contrast, LTa1b2 does not bind TNFR60 or TNFR80 (Crowe et al, 1994; Browning et al, 1993) and LTbR does not bind to secreted LTa homotrimer or to secreted or membrane forms of TNF (Crowe et al, 1994) . Thus, the LTb subunit provides the distinct LTbR specificity to the cell surface LTa1b2 heterotrimer. Although similar to TNFR60 and TNFR80 in its extracellular ligand binding domain, LTbR exhibits little sequence homology with these receptors in its cytoplasmic domain. However, functional similarities between LTbR, TNFR80 and CD40 are suggested by the findings that these receptors bind to a related set of signaling molecules, called TRAFs, which constitute a family of zinc ring finger proteins (Mosialos et al, 1995; Nakano et al, 1996) . LTbR induces a slow apoptotic death in certain adenocarcinomas and tumor growth arrest in vivo (Browning et al, 1996b) . Cell death induced by LTbR is dependent on TRAF3 (VanArsdale et al, 1997) , whereas NFKB activation appears to be mediated by TRAF5 or TRAF2 (Nakano et al, 1996) .
While the biological activities and signaling cascades elicited by TNF or LTa homotrimers binding to TNFR60 and TNFR80 have been extensively examined, less is known regarding the function of the LTbR/LTa1b2 interaction. The earliest hint to its function comes from findings that mice rendered deficient in LTa by targeted gene disruption display a loss of T and B cell organization in the spleen, an absence of Peyer's patches and lymph nodes and deficient germinal center formation with a conspicuous absence of follicular dendritic cells (FCD) and IgG production upon antigenic challenge (De Togni et al, 1994; Banks et al, 1995; Matsumoto et al, 1996a; Fu et al, 1997) . Some, but not all, of these phenotypic characteristics have been observed in mice with deficiencies in TNFR60 (Matsumoto et al, 1996b; Pfeffer et al, 1993; Rothe et al, 1993; Pasparakis et al, 1997) , but not in TNFR80 deficient mice (Erickson et al, 1994) , suggesting that the LTa homotrimer is not sufficient for the proper organization and function of these tissues. Thus, the binding of LTa1b2 to LTbR is implicated to play a role in lymphoid organogenesis and functional organization of lymphoid tissues. This idea is supported by recent studies demonstrating that LTb deficient mice lack Peyer's patches, peripheral lymph nodes, splenic germinal centers and follicular dendritic cells, but retain normal cervical and mesenteric lymph nodes (Koni et al, 1997; Alimzhanov et al, 1997) and that experimental mouse systems using soluble LTbR : Fc fusion protein result in deficient splenic architecture (Ettinger et al, 1996) and peripheral lymph node formation (Rennert et al, 1996) . Despite this strong evidence, little is known about the cells which express LTbR. Therefore, we examined the expression of LTbR on a variety of primary human cells and cell lines and developing human lymphoid tissues to identify the cell types involved in the control of lymphoid organization by the LTbR/LTa1b2 interaction.
Results

Comparison of LTbR expression to other TNF receptor family members
Using immunofluorescence and flow cytometry, we examined the cell surface expression of LTbR on a range of human cells of hematopoietic and non-hematopoietic origin and compared its expression to that of TNFR80, TNFR60, CD40 and Fas (CD95) ( Table 1) . In contrast to TNFR80, or Fas, LTbR is not expressed on resting or activated T cells or T leukemias. Both monoclonal and polyclonal goat antibodies to LTbR failed to react with T cells, excluding an epitope loss artifact. In contrast to CD40, LTbR is not expressed on an EBV transformed B cell line or a B cell lymphoma. Moderate expression of LTbR was detected on a number of leukemia cell lines, such as U937, HL60 and K562, which represent cells at various stages of myeloid differentiation. It was also found on several cell types of nonhematopoietic origin, such as the high level of expression found on ME-180 cervical carcinoma cells. This pattern of expression is similar, but not identical to that found for TNFR60.
Expression of LTbR on peripheral blood monocytes and dendritic cells (DC)
In light of our finding that several human myeloid leukemia lines express LTbR we also performed a careful analysis of LTbR expression on monocytes and DC obtained by elutriation from human peripheral blood. Figure 1A demonstrates the two populations of cells present in elutriated fractions of PBMC enriched for monocytes/DC. These fractions can be divided into CD33+, CD147 and CD33+, CD14+. We used three-color immunofluorescence to evaluate expression of CD83, HLA-DR and LTbR on these two populations immediately (day 0) or after 2 days in culture ( Figure 1B ). As previously described (Zhou and Tedder, 1995; O'Doherty et al, 1993) , CD33+, CD147 DC express CD83 after 2 days in culture, while CD33+, CD14+ monocytes fail to express this marker. Both populations express HLA-DR, but the DC express high levels of HLA-DR which are markedly enhanced following 2 days of culture. In contrast, neither population expresses LTbR at either time point.
Expression of LTbR in developing human thymus
Given that T cells are the predominant source of the LTa1b2 ligand Browning et al, 1991; Ware et al, 1992) and our previous finding that mRNA for LTbR is 1 Except for peripheral blood T cells, expression of TNFR was determined by single-color immuno¯uorescence and¯ow cytometry using the mAb and methods described in Materials and Methods. Fuorescence signal (peak mean channel)420-fold above staining with normal mouse Ig is denoted with +++; 5 ± 20-fold, ++; 2 ± 4-fold, +; not detected, 7. On activated T cells 7/+ denotes expression of CD40 depends on individual clone of human T cells and the level of CD40 on T cells is typically 10-fold less than that seen on B cell lines [25] .
2 Peripheral blood T cell subpopulations were detected by dual-color analysis with FITC-labeled anti-CD4 or anti-CD8 and biotin conjugated anti-TNFR and PE-conjugated strepavidin. The peripheral blood T cell data represents results from seven different donors with no difference noted between genders expressed in a murine thymic epithelial cell line (Force et al, 1994) , we used immunohistochemistry to examine the expression of LTbR protein in frozen sections of developing human thymus. In normal postnatal thymus (Figure 2A ), LTbR expression is most prominent in the medulla (M) and along the trabeculae (T). Specific staining for LTbR is detected in the stromal rudiment of fetal thymus as early as 14 weeks gestation and distinctly localized by 16 weeks gestation. During development, the trabeculae extend through the cortex and meet with the developing medulla at the corticomedullary junction (von Gaudecker and MullerHermelink, 1980; Kendall, 1989) . This is illustrated in Figure  2B , where LTbR expressing cells are apparent in the trabeculae, and within the medulla along the corticomedullary junction of a 20 week gestation thymus. In normal thymus, no significant changes in the level or localization of LTbR expression were observed from 20 weeks gestation to 22 months postnatal.
Colocalization of LTbR with reticular stromal cells in human thymus
To define the stromal cell types expressing LTbR we stained serial sections of postnatal human thymus with antibodies to reticular dendritic cells, LTbR or CD11c, which reacts with tissue macrophages (Lanier et al, 1985; Myones et al, 1988) . The results are shown in Figure 3 , where the pattern of staining for LTbR (B) is similar to that for reticular dendritic cells (A), but not that for CD11c (C). Most notable is the staining along the trabeculae, which are lined with reticular Figure 1 Analysis of LTbR expression on human peripheral blood monocytes and DC. Elutriated fractions containing peripheral blood monocytes and DC were stained with PE-conjugated anti-CD33 and FITC-conjugated anti-CD14 to differentiate between the two cell types. Monocytes (CD33+CD14+) and DC (CD33+CD147) were individually gated and further analyzed for CD83, HLA-DR or LTbR by three-color immunofluorescence. Expression patterns were obtained immediately upon isolation and after two days in culture Expression of lymphotoxin b receptor M Murphy et al dendritic cells (von Gaudecker and Muller-Hermelink, 1980; Kendall, 1989) , and the corticomedullary junction (arrows) where LTbR and the reticular dendritic cell antigens colocalize. In contrast, CD11c reacts with isolated cells along the trabeculae and numerous cells throughout the medulla. Sections of thymus stained with control goat serum or isotyped matched control mAbs showed no staining in cortex, medulla or trabeculae, and only faint, non-specific staining in Hassall's corpuscles.
Expression of LTbR in developing human spleen and colocalization with reticular dendritic cells
Given the splenic disorganization observed in LTa deficient mice we examined LTbR expression on frozen sections from ten samples of human fetal spleen ranging from 14 ± 22 weeks gestation. Expression of LTbR was observed throughout the splenic tissue as early as 14 weeks gestation. By 20 weeks, the developing spleen shows distinct regions of red pulp (R) and lymphocyte-rich white pulp (W). LTbR is more prominently observed in the red pulp ( Figure  4A ) and at high power it can be seen concentrated at the R/W border in a stromal pattern of expression ( Figure 4B ). Sections of spleen stained with a control goat serum showed no stromal staining and only faint, non-specific staining in central arterioles ( Figure 4C ). We also examined serial sections of spleen for expression of reticular dendritic cells with anti-LTbR and CD11c ( Figure 5 ). In this 17 week fetal spleen clear demarcation of the red and white pulp had not yet occurred. Specific staining for LTbR is present on stromal cells throughout the tissue (B) and the pattern of expression is similar to that of the reticular dendritic cell antigen (A), but not for CD11c positive tissue macrophages (C). Our findings that LTbOR is expressed on stromal cells rather than lymphocytes in lymphoid tissues is consistent with the results shown in Table 1 and suggests that non-hematopoietic cells such as reticular dendritic cells express this receptor. To verify this hypothesis we used immunofluorescence and flow cytometry to examine expression of LTbR and other TNFR family members on a human follicular dendritic cell line, FDC-1, which is representative of this lineage of cells ( Figure 6 ). As previously described (Clark et al, 1992) , this line expresses CD40. These cells also express relatively high levels of LTbR, Fas and TNFR60, while staining with antibody to TNFR80 was undetectable on FDC-1 when compared to normal IgG control.
Ligation of LTbR with LTa1b2 enhances ICAM-1 (CD54) expression on FDC-1
To verify that the expression of LTbR on FDC-1 has functional significance, we cultured FDC-1 in the presence of TNF or a soluble form of LTa1b2 and examined the expression of . As described (Clark et al, 1992) , these cells constitutively express low levels of ICAM-1, which is markedly induced by TNF. We observed that soluble LTa1b2 also induced ICAM-1 on these cells after only 1 day in culture and that this level was enhanced to that found with TNF by 3 days in culture. As LTbR is the only known receptor for LTa1b2 (Crowe et al, 1994; Browning et al, 1993) , these data suggest that LTbR ligation results in a functional signal on this cell line.
Discussion
Characterization of LTbR expression in primary human peripheral blood cells and cell lines indicate that this receptor is not expressed on T or B lymphocytes and has a pattern of expression which is different from that of CD40, fas, TNFR60 and TNFR80. LTbR is also not expressed on resting, peripheral blood derived monocytes or DC (Figure 1 ). The fact that it was found at low levels on several myeloid cell lines (Table 1) suggests that LTbR may be present on immature or activated cells of the myeloid lineage. The LTa1b2 ligand for LTbR exists in a cell surface form which is expressed predominantly by activated T cells, but also by activated B cells and NK cells (Crowe et al, 1994; Androlewicz et al, 1992; Browning et al, 1991 Browning et al, , 1993 Ware et al, 1992) , suggesting a more restricted function for this receptor through direct cellular interaction with T cells. The fact that LTbR is expressed on stromal cells in lynphoid organs, sites where cellular interaction with T cells is likely to occur, strengthens this hypothesis. Our finding of LTbR expression on stromal cells in human thymus is consistent with a previous report of LTbR mRNA expression in murine thymus and in a medullary thymic epithelial cell line (Force et al, 1996) . Thus far, activated mature T cells have been shown to express LTa1b2. However, mRNA for LTa and LTb have been detected in thymus (Browning et al, 1993) , suggesting that immature thymocytes may also express this ligand. Despite these expression patterns, no obvious thymic abnormalities were reported in LTa or LTb deficient mice or in mice treated with soluble LTbR : Fc fusion protein. It is possible that LTbR binds an alternative ligand in developing human thymus or that other cytokines are involved in thymic organogenesis.
Our observation of LTbR expression on reticular dendritic cells in the developing human spleen is consistent with the findings that mice transgenic for LTa under the control of the rat insulin promoter develop an accumulation of lymphocytes in the pancreas which strongly resembles de novo lymphoid organogenesis (Kratz et al, 1996) . Reticular dendritic cells are present in the red pulp and along the marginal areas which form a barrier between the red pulp and white pulp through which lymphocytes traverse (Weiss, 1972) . As LTbR expression is most prominent in the red pulp it is important to note that the organization of the lymphoid elements within the spleen may involve signals delivered not only by lymphocytes, but also by stromal cells such as reticular dendritic cells. The LTa1b2 ligand exists as a cell surface protein on activated lymphocytes and is not secreted (Browning et al, 1991; Ware et al, 1992) , whereas LTbR is present on reticular stromal cells, suggesting that this ligand/receptor interaction is through direct cellular contact between these two cell types. FDC are believed to be derived from reticular stromal cells (Yoshida et al, 1995) which accumulate in the lymphoid follicles upon antigen stimulation and play an important role in B cell maturation in lymphoid tissues (Rajewsky et al, 1987; Szakal et al, 1989; Clark and Ledbetter, 1994) . The importance of T and B cell interactions in lymphoid follicles has also been recently emphasized by the involvement of CD40 and CD40 ligand (Clark and Ledbetter, 1994) , also members of the TNFR/ TNF family. The expression of LTbR on the FDC-1 cell line, as well as our finding that ligation of this receptor results in induction of ICAM-1 on these cells, suggests that the LTa1b2 ligand on activated T or B cells, also found in lymphoid follicles (Rajewsky et al, 1987; Szakal et al, 1989; Clark and Ledbetter, 1994) , interacts with LTbR on follicular stromal cells to influence the B cell maturation process. This hypothesis is supported by the recent finding that reconstitution of normal mice with bone marrow from LTa deficient mice results in loss of FDC clustering, germinal center formation and Ig class switching (Fu et al, 1997) . Interestingly, mice deficient in TNF (Pasparakis et al, 1997) and TNFR60 (Matsumoto et al, 1996a,b; Pasparakis et al, 1997 ) also show failure of germinal center formation and FDC clustering with less dramatic effects on lymphoid organogenesis (Pasparakis et al, 1997) . This result is consistent with our finding of TNFR60 on the FDC-1 cell line and suggests that both LTbR and TNFR60 signaling are important in FDC clustering and germinal center formation. In constrast to LTa deficient mice, LTb knockout mice retain cervical and mesenteric lymphnodes and the disorganization of T and B cells in the spleen is not as severe (Koni et al, 1997; Alimzhanov et al, 1997) suggesting that LTa may engage another receptor.
In summary, our findings demonstrate that LTbR is present in human thymus and spleen at early stages of development and is localized to reticular dendritic cells, and not lymphocytes. The early expression and localization of this receptor on stromal cells implies that the interaction with cell surface LTa1b2 may be important in organization of these tissues. Additionally, our finding that LTbR is expressed on FDC-1 helps to explain the abnormalities in FDC clusters and antibody production observed in LTa and LTb deficient mice and suggests that the LTa1b2/LTbR interaction plays an important role in lymphocyte interactions with FDC in the germinal center.
Materials and Methods
Antibodies
The following anti-human mAbs were used for flow cytometry: AntiLTbR BDA8 mouse IgG1 biotin-conjugated and unconjugated forms (Browning et al, 1996b) , anti-TNFR80 M1 rat IgG2b, , anti-TNFR60 H398 mouse IgG2b (Bender Med Systems, Vienna Austria), anti-CD40 G28-5 mouse IgGI (a gift from E. Clark, University of Washington, Seattle, WA), anti-Fas CH-11 mouse IgM (Pan Vera Inc, Madison, WI), anti-CD4 SK3 mouse IgG1 and anti-CD8 SKI mouse IgG1 FITC-conjugated (Becton Dickinson Immunocytochemistry Systems, San Jose, CA), anti-HLA-DR B8.11.2 mouse IgG2a biotin-conjugated (provided by J. van de Winkel, Utrecht, The Netherlands), anti-CD14 AML-223 mouse IgG2b FITC-conjugated (Medarex, Inc, Annandale, NJ), anti-CD33 4D3 mouse IgG2b PE conjugated (Caltag Laboratories, Inc., San Francisco), anti-CD83 HB15a mouse IgG2b biotin-conjugated (a gift from T. Tedder; Duke University Medical Center, Durham, NC), anti-CD54, ICAM-1, mouse IgG1 (Chemicon International, Temecula, CA). Isotype matched control mAb were obtained from Medarex. TRI-COLOR-labeled streptavidin, PE and FITC-labeled F(ab') 2 goat-anti-mouse lg, and PE-streptavidin were obtained from Caltag.
For immunohistochemistry serum specific for human LTbR was collected from goats immunized with a human LTbR : Fc fusion protein (Crowe et al, 1994) and adsorbed with human IgG to remove human Fc reactivity as described . The goat antiLTbR has no crossreactivity with TNFR60, TNFR80 or Fas (CD95) as measured by competitive radiobinding assays, immunoprecipitation or flow cytometry. Purified serum was used at a 1 : 1000 dilution (approx. 10 mg/ml) for immunohistochemistry. Murine mAbs 12B1 (IgG2a, Immunotech, Inc., Westbrook, ME) and anti-gp150,95 (IgG2b, Becton Dickinson), reactive with reticular dentritic cells (Farace et al, 1986) and CD11c on tissue macrophages (Lanier et al, 1985; Myones et al, 1988) , respectively, were used at 10 mg/ml. Pre-immune goat serum was similarly treated by passage over immobilized human IgG column and used at similar dilutions for controls. Isotype-matched IgG (Organon-Teknika, West Chester, PA) were used as negative controls for mouse mAbs. Purified recombinant TNF and LTa1b2 (Browning et al, 1996a) were provided by Biogen, Inc.
Cell lines
The human cell lines HUT-78, Molt4, U937, HL60, K562, WI-38, HEK293 and ME-180 described in Table 1 were purchased from the American Type Tissue Collection (ATCC, Rockville, MD). The B cell-2, -3 and BJAB lines were obtained from E. Kieff and G. Mosialos (Harvard University, Boston, MA). B cell-3 was derived from a B cell enriched fraction of human peripheral blood cells infected with Epstein-Barr virus (EBV) carried in the marmoset B95-8 cell line. BJAB is from an EBV negative Burkitt's lymphoma. The human T cell line Jurkat (clone E6-1) was obtained from the NIH AIDS Research and Reference Reagent Program. The human follicular dendritic cell line FDC-1 (Clark et al, 1992 ) was a gift from E. Clark (University of Washington, Seattle, WA).
Human peripheral blood T cells, monocytes and dendritic cells (DC)
PBMC from healthy volunteers were obtained by F/H density gradient centrifugation (Boyum, 1968) . Activated T cells were prepared by culture of PBMC for 5 ± 8 days in RPMI-1640 containing 10% FCS, anti-CD3 (OKT3, 10 ng/ml) and, after 3 days, with IL-2 (10 ng/ml) as Expression of lymphotoxin b receptor M Murphy et al described . For experiments in Table 1 these activated T cells were distinguished as CD4 or CD8 by immunofluorescence and flow cytometry using FITC-labeled anti-CD4 or CD8 and analyzed for expression of TNFRs with biotinylated mAbs and PEstreptavidin.
Blood dendritic cells (DC) and monocytes were enriched using countercurrent elutriation as previously described (Fanger et al, 1996) . Briefly, PBMC were loaded onto the JE-6B elutriator (Beckman, Palo Alto, CA) and 50 ml fractions were collected while increasing the flow rate from 30 to 45 ml/min at 2500 r.p.m. Elutriated fractions consisting of fewer than 10% lymphocytes were obtained using this procedure and monocytes (CD33+, CD14+) and DC (CD33+, CD147) could be distinguished. For experiments described enriched monocyte/DC fractions were analyzed for expression of CD33, CD14 and either CD83, HLA-DR or LTbR by three-color immunofluorescence and flow cytometry immediately (day 0) or following 2 days of culture in HEPES RPMI 1640 (Gibco, Grand Island, NY) containing 10% pooled human serum at 5610 5 cells per well in a 96 well plate. 
Human thymus and spleen
Immunohistochemistry
Immunohistochemistry for human tissues was performed on acetone fixed frozen sections using Vector ABC Elite reagents (Vector Laboratories, Inc., Burlingame, CA). Modifications included the use of 3% blocking rabbit serum, dilution of antibodies in blocking serum, quenching of endogenous peroxidase in 0.3% H 2 0 2 in MeOH following reactivity with biotinylated secondary antibody and detection of specific peroxidase activity using Nickel-DAB (Pierce, Rockford, IL) and DAB Enhancing Solution (Vector Laboratories). Where indicated, sections were counterstained with 0.1% methyl green.
Immuno¯uorescence and¯ow cytometry
Cell analysis was performed on a FACScan (Becton Dickinson, San Jose, CA) with more than 5000 cells analyzed per sample. For single color immunofluorescence, cell suspensions (5610 5 cells in 20 ml) were incubated for 1 h at 48C with 20 ml of mAb at optimal concentrations. When necessary, 20 ml human IgG (12 mg/ml, Sigma, St. Louis, MO) was added to block Fc receptor binding. Following three washes with 200 ml PBS containing 2 mg/ml BSA, 40 ml of PE-labeled F(ab')2 goat-anti-mouse Ig (20 mg/ml) was added for an additional 1 h. For dual color immunofluorescence with anti-CD4 or anti-CD8 FITC, biotin-conjugated primary mAbs and PE-streptavidin were used. Cells were washed three times, resuspended in PBS-BSA for immediate analysis or PBS-BSA supplemented with 1% paraformaldehyde for analysis 1 to 7 days later. For three-color analysis cells were incubated with biotinylated primary antibody, washed as above, then followed with TRI-COLOR Streptavidin, PEanti-CD33 and FITC-anti-CD 14, washed and fixed as above.
